# BORTEZOMIB
> **NDA215441** · New Drug Application · Sponsor: ACCORD HLTHCARE · Approved 2022-07-26
## Drug
- **FDA Application Number:** NDA215441
- **Application type:** New Drug Application
- **Brand name:** BORTEZOMIB
- **Generic name:** Bortezomib
- **Active ingredients:** BORTEZOMIB
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** ACCORD HLTHCARE
- **First approval:** 2022-07-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215441)
---
*AI Analytics · CC0 1.0*